Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous acetaminophen versus oral ibuprofen for PDA closure in preterm newborns
IRCT20190206042639N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of acetaminophen and ibuprofen in patent ductus arteriosus (PDA) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: closure of PDA, need for drug re-treatment and 8 more. Started Aug 2016; status: completed.
02
Drugs
acetaminophenibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on IRCT20190206042639N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190206042639N1.